Servicios Personalizados
Revista
Articulo
Inglés (pdf)
Articulo en XML
Referencias del artículo
Traducción automática
Enviar articulo por emailIndicadores
Citado por SciELO 
Accesos
Links relacionados
Citado por Google 
Similares en
SciELO 
Similares en Google
Compartir
Permalink
Revista Colombiana de Reumatología
versión impresa ISSN 0121-8123
Resumen
GUERRERO, Andrea Cevallos et al. Treatment adherence in patients with diffuse neuropsychiatrie disorders associated with systemic lupus erythematosus. Rev.Colomb.Reumatol. [online]. 2022, vol.29, n.1, pp.26-30. Epub 12-Ene-2023. ISSN 0121-8123. https://doi.org/10.1016/j.rcreu.2020.12.003.
Introduction:
Systemic lupus erythematosus (SLE) is a chronic disease that affects multiple systems and may include neurological and psychiatric events that could compromise treatment adherence and long-term outcomes in SLE.
Objective:
To evaluate treatment adherence in patients with diffuse neuropsychiatric disorders associated with SLE.
Methods:
A cross-sectional descriptive study was conducted. Treatment adherence was eval uated with the Morisky Medication Adherence Scale (MMAS-8) in patients with diffuse neuropsychiatric disorders associated with SLE (cognitive impairment, psychosis, mood disorders, and anxiety).
Results:
A total of 60 patients with neuropsychiatric disorders associated with SLE were included. Thirteen patients (21.6%) had high adherence, 9 (15%) had medium adherence, and 38 patients (63.3%) had low treatment adherence.
Conclusion:
This study has identified that almost two-thirds of the participants (63.3%) had low treatment adherence.
Palabras clave : Neuropsychiatry; Lupus; Adherence; Anxiety; Depression; Ecuador.
